Press Room

Axichem is an innovative biotechnology company specialising in development of natural analogue, safe components.

Read more
All Press Releases
Financial Reports
News
SubscribePress Contact
Press releases
April 28, 2025
aXivite driver rekordefterfrågan då Triquetra Healths GLP-Activate[™] klättrar till toppförsäljning
aXichem AB (publ), (aXichem), som utvecklar innovativa naturanaloga fodertillsatser och Read the article here
April 28, 2025
aXivite fuels record demand as Triquetra Health’s GLP-Activate[™] climbs to top-seller status
aXichem AB (publ), (aXichem), the developer of innovative natural analogue Read the article here
April 16, 2025
aXichem utser Erik Lager till Chief Operating Officer, för att möta tillväxtfasens ökade behov av en kvalitetssäkrad leveransprocess
aXichem AB (publ), (aXichem), som utvecklar naturanaloga fodertillsatser och kosttillskottsingredienser, Read the article here
April 16, 2025
aXichem appoints Erik Lager as Chief Operating Officer, to meet the growth phase’s increased need for a quality-assured delivery process
aXichem AB (publ), (aXichem), developer of innovative natural analogue feed Read the article here
March 18, 2025
aXichem upptar kreditfacilitet med stöd från EIF, för fortsatt etablering av aXiphen i Brasilien
aXichem AB (publ), (aXichem), som utvecklar naturanaloga fodertillsatser och kosttillskottsingredienser, Read the article here
March 18, 2025
aXichem takes up credit facility with support from EIF, for continued establishment of aXiphen in Brazil
aXichem AB (publ), (aXichem), developer of innovative natural analogue feed Read the article here
March 05, 2025
aXichem meddelar preliminära resultat från CrossFit Performance-studie med aXivite, indikerande avsevärd förbättring av uthållighet och återhämtning
aXichem AB (publ), (aXichem), som utvecklar innovativa naturanaloga fodertillsatser och Read the article here
March 05, 2025
aXichem Announces Preliminary Findings from CrossFit Performance Study with aXivite, Indicating Unmatched Endurance and Recovery Gains
aXichem AB (publ), (aXichem), the developer of innovative natural analogue Read the article here
February 27, 2025
aXichem AB (publ) Bokslutskommuniké, januari – december 2024
aXichems utveckling under perioden 2024-01-01—2024-12-31 I denna delårsrapport presenteras koncernen Read the article here
February 27, 2025
aXichem AB (publ) Year End Report, January – December 2024
aXichem’s development during the period 2024-01-01—2024-12-31 In this interim report, Read the article here
February 25, 2025
aXichem’s CEO Torsten Helsing Presents the Year End Report 2024 in a Live Web Conference
aXichem AB (publ), publishes its Year End Report for 2024 Read the article here
February 25, 2025
aXichems VD Torsten Helsing presenterar bokslutskommuniké 2024 i en direktsänd webbkonferens
aXichem AB (publ), offentliggör sin bokslutskommuniké för 2024 torsdagen den Read the article here
February 12, 2025
aXichem erhåller order från Chr. Olesen avseende aXiphen till ett värde av cirka 7 miljoner kronor
aXichem AB (publ), (aXichem), som utvecklar som utvecklar naturanaloga fodertillsatser Read the article here
February 12, 2025
aXichem receives order from Chr. Olesen regarding aXiphen to a value of approximately SEK 7 million
aXichem AB (publ), (aXichem), the developer of innovative natural analogue Read the article here
February 04, 2025
aXichem uppdaterar status för komplettering av Feed Additive-ansökan i EU för phenylcapsaicin
aXichem AB (publ), som utvecklar naturanaloga foder- och kosttillskottsingredienser, meddelar Read the article here
February 04, 2025
aXichem updates status regarding completion of Feed Additive application in the EU for phenylcapsaicin
aXichem AB (publ), developer of innovative natural analogue feed additives Read the article here
SubscribePress Contact